Free Trial

Townsquare Capital LLC Lowers Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Townsquare Capital LLC lessened its holdings in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 10.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 118,826 shares of the company's stock after selling 13,157 shares during the quarter. Townsquare Capital LLC's holdings in Procter & Gamble were worth $20,581,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. Carlson Capital Management acquired a new position in Procter & Gamble during the third quarter worth approximately $215,000. Shum Financial Group Inc. acquired a new stake in shares of Procter & Gamble during the 3rd quarter worth $1,227,000. Lazard Freres Gestion S.A.S. raised its position in shares of Procter & Gamble by 3.4% in the 3rd quarter. Lazard Freres Gestion S.A.S. now owns 265,564 shares of the company's stock worth $45,995,000 after buying an additional 8,856 shares during the period. Principal Street Partners LLC boosted its holdings in Procter & Gamble by 79.1% in the third quarter. Principal Street Partners LLC now owns 7,040 shares of the company's stock valued at $1,164,000 after acquiring an additional 3,110 shares during the last quarter. Finally, Sanders Capital LLC grew its position in Procter & Gamble by 1.2% during the third quarter. Sanders Capital LLC now owns 7,249,547 shares of the company's stock valued at $1,255,622,000 after acquiring an additional 88,649 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Procter & Gamble Stock Up 1.1 %

NYSE:PG opened at $179.31 on Wednesday. The stock has a 50-day simple moving average of $170.11 and a 200 day simple moving average of $168.83. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $179.46. The company has a market capitalization of $422.28 billion, a price-to-earnings ratio of 30.92, a price-to-earnings-growth ratio of 3.82 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the business earned $1.83 EPS. The business's quarterly revenue was down .6% on a year-over-year basis. Sell-side analysts predict that The Procter & Gamble Company will post 6.96 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.25%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 69.48%.

Wall Street Analysts Forecast Growth

PG has been the topic of several research analyst reports. JPMorgan Chase & Co. lifted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research note on Thursday, September 19th. Royal Bank of Canada reissued a "sector perform" rating and issued a $164.00 price objective on shares of Procter & Gamble in a research report on Monday, October 21st. Piper Sandler initiated coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a "neutral" rating and a $174.00 price target for the company. StockNews.com lowered Procter & Gamble from a "buy" rating to a "hold" rating in a research report on Thursday, August 1st. Finally, Evercore ISI upped their target price on Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $180.45.

Check Out Our Latest Stock Analysis on Procter & Gamble

Insider Activity at Procter & Gamble

In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the sale, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Susan Street Whaley sold 634 shares of the company's stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the transaction, the insider now owns 19,341 shares of the company's stock, valued at approximately $3,319,882.65. This trade represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 35,233 shares of company stock valued at $6,024,234 in the last quarter. Insiders own 0.18% of the company's stock.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG - Free Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs
How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines